ストックスクリーナーアプリを入手
1.64
3.53%
-0.06
アフターアワーズ：
1.64
前日終値:
$1.70
開ける：
$1.68
24時間の取引高:
653.45K
Relative Volume:
1.41
時価総額：
$163.07M
収益：
$32.38M
当期純損益:
$-21.64M
株価収益率:
-6.5157
EPS:
-0.2517
ネットキャッシュフロー:
$-13.78M
1週間 パフォーマンス:
-13.23%
1か月 パフォーマンス:
-10.87%
6か月 パフォーマンス:
-38.81%
1年 パフォーマンス:
-27.11%
1日の値動き範囲:
$1.60
$1.685
1週間の範囲:
$1.60
$1.94
52週間の値動き範囲:
$1.59
$3.59
Stereotaxis Inc Stock (STXS) Company Profile
名前
Stereotaxis Inc
セクター
電話
314-678-6100
住所
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS vs ISRG, BDX, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
1.64 | 169.03M | 32.38M | -21.64M | -13.78M | -0.2517 |
ISRG
Intuitive Surgical Inc
|
407.12 | 144.07B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
153.83 | 41.87B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
40.58 | 34.70B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
69.00 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
198.50 | 29.57B | 5.54B | 1.52B | 1.74B | 10.37 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-16 | 開始されました | Citizens JMP | Mkt Outperform |
| 2024-01-10 | 開始されました | ROTH MKM | Buy |
| 2022-07-12 | 開始されました | Aegis Capital | Buy |
| 2022-06-23 | 開始されました | B. Riley Securities | Buy |
| 2022-01-05 | 開始されました | Craig Hallum | Buy |
| 2022-01-05 | 開始されました | Loop Capital | Buy |
| 2021-05-26 | 開始されました | Piper Sandler | Overweight |
| 2020-09-08 | 開始されました | Northland Capital | Outperform |
| 2020-04-09 | 開始されました | Cowen | Outperform |
| 2020-04-07 | 開始されました | Lake Street | Buy |
すべてを表示
Stereotaxis Inc (STXS) 最新ニュース
ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now? - TradingView
Stereotaxis closes Robocath takeover - Yahoo Finance
Stereotaxis, Inc. completes Robocath acquisition to accelerate endovascular robotics expansion - Traders Union
Stereotaxis completes acquisition of Robocath - Investing.com
Robocath deal adds stock, warrants and earnouts at Stereotaxis (STXS) - Stock Titan
Stereotaxis folds Robocath into its surgical robotics platform - Stock Titan
Enterprise value to revenue forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Price to sales forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Enterprise value to EBITDA forward of Stereotaxis, Inc. – LS:A1J09L - TradingView
Price to book forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Director Ross B. Levin receives 43,103 Stereotaxis (STXS) restricted share units - Stock Titan
Director at Stereotaxis (STXS) receives 43,103-share equity grant - Stock Titan
Stereotaxis (STXS) director awarded 43,103 restricted share units, holding 1,035,560 shares - Stock Titan
Robotics redefine electrophysiology, Stereotaxis, Inc. explores in latest podcast - Traders Union
STXS Q1 2026 Earnings: EPS Misses Estimates as Stock SlipsWeak Earnings Momentum - dars.gov.et
Stereotaxis (STXS) director awarded 43,103 restricted share units in grant - Stock Titan
Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Growth For Stereotaxis (STXS) - Yahoo Finance
Stereotaxis Inc. (STXS) Holds Near Support Amidst Low VolatilityMomentum Stock Picks - dars.gov.et
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 2000 Value Benchmark - marketscreener.com
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Price to earnings forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
STXSStereotaxis Inc Options - Finviz
Stereotaxis, Inc. Hits New 52-Week Low at $1.60 Amid Decline - MarketsMojo
Stereotaxis (STXS) Gains 3.7% as Stock Hovers Near Key ResistanceSymmetrical Triangle - dars.gov.et
8 Most Promising Robotics Stocks Now - Insider Monkey
Enterprise value to EBIT forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Enterprise value to revenue forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView
Price to sales forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView
Stereotaxis, Inc. Actuals & Estimates (AMEX:STXS) - TradingView
Stereotaxis, Inc. Actuals & Estimates (DUS:RJR1) - TradingView
STXS Forecast — Price Target — Prediction for 2027 - TradingView
Stereotaxis | 4: Statement of changes in beneficial ownership of securities-Officer Peery Kimberly R. - Moomoo
Stereotaxis Inc (STXS) Institutional Confidence - TradingKey
Stereotaxis, Inc. publishes new robotics case study in electrophysiology - Traders Union
Top Endovascular Robotic Systems Companies Driving the Future of Vascular Care - Fortune Business Insights
STXS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Stereotaxis, Inc. unveils online demo platform for advanced robotic cath lab - Traders Union
Stereotaxis Inc (STXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Stereotaxis Inc (STXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Stereotaxis Inc (STXS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Stereotaxis Inc (STXS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Stereotaxis Inc (STXS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Stereotaxis Inc (STXS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Stereotaxis Inc (STXS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Stereotaxis Inc (STXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Stereotaxis, Inc. unveils Synchrony system to enhance cath lab workflow with single high resolution display - Traders Union
Q1 2026 Stereotaxis Inc Earnings Call Transcript - GuruFocus
Stereotaxis Q1 2026 Earnings: EPS Miss as Company Reports Wider-than-Expected LossEarnings Deceleration Risk - DonanımHaber
Stereotaxis eyes billions in market opportunity with Robocath takeover - MSN
MAGiC system delivers enhanced precision and control in arrhythmia care - Traders Union
Stereotaxis Inc (STXS) 財務データ
収益
当期純利益
現金流量
EPS
0.22%
0.64%
大文字化:
|
ボリューム (24 時間):